However, further analysis of the differences in cytokines profiles between MS+ and MS– subjects (Figure 4A) revealed a difference in in vitro CXCL8 ratio between MS+, MS– patients and healthy controls (Figure 4B). Here, CXCL8 is linked to myeloid sarcoma.